Vimian Group AB Stock

Equities

VIMIAN

SE0015961982

Pharmaceuticals

Market Closed - Nasdaq Stockholm 11:29:56 2024-04-17 am EDT 5-day change 1st Jan Change
31.8 SEK +0.32% Intraday chart for Vimian Group AB -2.30% +7.43%

Financials

Sales 2024 * 371M 395M 4.32B Sales 2025 * 419M 445M 4.88B Capitalization 1.42B 1.51B 16.58B
Net income 2024 * 40M 42.54M 466M Net income 2025 * 62M 65.93M 722M EV / Sales 2024 * 4.54 x
Net Debt 2024 * 262M 279M 3.06B Net Debt 2025 * 176M 188M 2.05B EV / Sales 2025 * 3.82 x
P/E ratio 2024 *
34.7 x
P/E ratio 2025 *
21.8 x
Employees 1,100
Yield 2024 *
-
Yield 2025 *
-
Free-Float 40.37%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Vimian Group AB

1 day+0.95%
1 week-1.69%
Current month-1.54%
1 month+2.43%
3 months+22.32%
6 months+44.27%
Current year+8.11%
More quotes
1 week
31.05
Extreme 31.05
35.40
1 month
28.54
Extreme 28.54
35.40
Current year
25.14
Extreme 25.14
35.40
1 year
20.08
Extreme 20.08
37.96
3 years
20.08
Extreme 20.08
123.40
5 years
20.08
Extreme 20.08
123.40
10 years
20.08
Extreme 20.08
123.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 Dec. 31
Director of Finance/CFO 45 21-12-31
Investor Relations Contact 43 21-08-31
Members of the board TitleAgeSince
Director/Board Member 65 20-12-31
Director/Board Member 57 21-12-31
Director/Board Member 54 22-12-31
More insiders
Date Price Change Volume
24-04-17 31.8 +0.32% 203 365
24-04-16 31.7 -1.55% 288,930
24-04-15 32.2 -1.23% 1,095,085
24-04-12 32.6 -2.83% 142,990
24-04-11 33.55 +3.07% 413,389

Delayed Quote Nasdaq Stockholm, April 17, 2024 at 07:53 am EDT

More quotes
Vimian Group AB is a Sweden-based veterinary company. The Company is a parent company of the group of companies operating with a purpose of improving animal health through science and technology. The Group delivers solutions to veterinary professionals, labs and pet parents around the world. The purpose of Vimian Group is to unite companies in selected niches of animal health and help them grow faster. The Company invests in innovation and new technologies to advance veterinary medicine. The Group covers four essential and rapidly evolving areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. Vimian provides individual businesses with access to its networks, advisory services, infrastructure and capital.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
2.726 EUR
Average target price
3.365 EUR
Spread / Average Target
+23.44%
Consensus
  1. Stock Market
  2. Equities
  3. VIMIAN Stock